Vaccinia virus: a selectable eukaryotic cloning and expression vector.
about
The Jenner bicentenary; still uses for smallpox vaccineExpression of the UL16 glycoprotein of Human Cytomegalovirus protects the virus-infected cell from attack by natural killer cellsEnzymatic processing of replication and recombination intermediates by the vaccinia virus DNA polymeraseCombined prime-boost vaccination against tick-borne encephalitis (TBE) using a recombinant vaccinia virus and a bacterial plasmid both expressing TBE virus non-structural NS1 proteinPoxvirus vectors as HIV/AIDS vaccines in humansThe evolution of poxvirus vaccinesLive-Cell Imaging of Vaccinia Virus Recombination.Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expressionStructural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunityMonoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophagesEukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymeraseProspective surveillance for cardiac adverse events in healthy adults receiving modified vaccinia Ankara vaccines: a systematic reviewHuman poxvirus infection after the eradication of smallpoxMetalloproteinase Activity Secreted by Fibrogenic Cells in the Processing of Prolysyl OxidaseExpression of the P-protein of the human hepatitis B virus in a vaccinia virus system and detection of the nucleocapsid-associated P-gene product by radiolabelling at newly introduced phosphorylation sites.Homotypic and heterotypic exclusion of vesicular stomatitis virus replication by high levels of recombinant polymerase protein LRecombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapyProtection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion proteinA poxvirus-derived vector that directs high levels of expression of cloned genes in mammalian cells.Reverse genetics of negative-strand RNA viruses: closing the circleNovel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral ProteinsHighly attenuated vaccinia virus mutants for the generation of safe recombinant virusesImmune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein.Virus-vectored influenza virus vaccines.Generation of recombinant Orf virus using an enhanced green fluorescent protein reporter gene as a selectable markerA novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in ChinaExpression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection.Insertion and deletion mutagenesis of the human cytomegalovirus genomeApplications of pox virus vectors to vaccination: an update.A stimulating way to improve T cell responses to poxvirus-vectored vaccinesProtection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccineMolluscum contagiosum virus interleukin-18 (IL-18) binding protein is secreted as a full-length form that binds cell surface glycosaminoglycans through the C-terminal tail and a furin-cleaved form with only the IL-18 binding domainElicitation of both anti HIV-1 Env humoral and cellular immunities by replicating vaccinia prime Sendai virus boost regimen and boosting by CD40LmFoot-and-mouth disease.Varicella-zoster virus as a live vector for the expression of foreign genes.Expression of P1-450 and P3-450 DNA coding sequences as enzymatically active cytochromes P-450 in mammalian cells.New hope for an AIDS vaccine.Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trialsThe development of an AIDS vaccine: progress and promise.A novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responses
P2860
Q24650479-2A3B5C9C-549E-4B1B-A070-03E34213A775Q24793218-1EB346E8-8F9D-486D-A7B6-5FFC518D77FFQ24805912-18AD2332-3EEA-47DD-BBCB-532146BB752AQ24813809-6785314F-EB11-41CB-846E-81A9CAB12C21Q26995078-4CD304DF-7931-4362-B395-1E879ED4D6BBQ26995905-4AE9F174-3624-443D-B4CA-A21FAD135CE7Q27312228-F7A79952-AB12-482A-AA35-C7F3EA873A12Q27469703-039DFC6D-D2FE-4198-ABF6-1995ABF5941CQ27486161-2DF07982-4D12-47AA-9E30-EE66BB44BDCAQ27486215-C59BC165-AF4E-48EC-B6E8-83EC4A6A24B7Q27860943-56053569-DE78-4816-B4A2-FB57F3581209Q28485174-69944AEA-50FD-4511-A70B-EC58BD4000E2Q28767649-4BA2CE67-F4CC-4FC1-AA9A-68F809789F32Q29544584-41A7A8DA-2079-4313-B523-71CA9C4D5A68Q30334385-6EA21CF0-1FE2-430E-B2F3-282FD33754DAQ30452224-66C5ACEC-3CB8-4E53-92A4-EBD3C9B1F344Q33552626-40241B86-8363-4D6B-B609-2123EC2AB70EQ33554501-115DA5DA-A614-4F57-854E-F9B45FE59649Q33684465-12708657-6163-4816-AF92-041FD33E72D5Q33701942-EB3B6368-859C-4837-9E1C-2D13EDC7DD5DQ33770634-5326CB84-CD1D-4383-B477-BAE020646CA7Q33838030-1CBE8836-83B0-4DCF-BA25-2D6CC7E98096Q34080569-B073C64B-C2A2-4FA6-84D5-DA5A8A47DB79Q34102268-9ED29631-DA0F-4D93-86AA-9C0F7BFD9FBFQ34109044-A2A3CB94-702C-4C53-B6B1-F831EE1B4829Q34206208-AAD37A65-9019-413C-A0B0-F620F3FFF6E4Q34340404-0752534F-8E0D-4D94-B020-122280416D54Q34354191-87AF6037-7F6F-4B92-93F7-75E14DFE7A22Q34403246-F4303DE3-8243-4837-BE72-113C75D54677Q34429078-7A28BC93-1670-4239-9A5E-A58BDDEEA5E9Q34431934-76910585-B7AC-44ED-81DD-04CC0342CFACQ34472096-ECE28CC8-B1FA-454B-8F85-91538A879FE7Q34511092-30927D58-2E2D-4568-8F47-9B410946DA8BQ34547126-2A17E838-024F-4313-9A34-A7891076A04EQ34629086-0B1B3A4A-9213-412B-90FC-F5C0AE1B889EQ34631133-9F290AF5-E29C-4FD6-B094-77DD0678CC19Q34632063-824AF555-C096-4648-8150-AFC475F52B4CQ34671806-E3F312CC-2E69-422E-9A68-2995FFE2EB46Q34675856-68449178-7BCF-4878-A034-D92AD36F6B8DQ34952043-13DFE912-A8CF-4B0F-8F5A-BE48EA24A554
P2860
Vaccinia virus: a selectable eukaryotic cloning and expression vector.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh
1982年學術文章
@zh-hant
name
Vaccinia virus: a selectable eukaryotic cloning and expression vector.
@ast
Vaccinia virus: a selectable eukaryotic cloning and expression vector.
@en
type
label
Vaccinia virus: a selectable eukaryotic cloning and expression vector.
@ast
Vaccinia virus: a selectable eukaryotic cloning and expression vector.
@en
prefLabel
Vaccinia virus: a selectable eukaryotic cloning and expression vector.
@ast
Vaccinia virus: a selectable eukaryotic cloning and expression vector.
@en
P2093
P2860
P356
P1476
Vaccinia virus: a selectable eukaryotic cloning and expression vector.
@en
P2093
P2860
P304
P356
10.1073/PNAS.79.23.7415
P407
P577
1982-12-01T00:00:00Z